Compare LENZ & ANGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LENZ | ANGI |
|---|---|---|
| Founded | 2019 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 278.4M | 266.7M |
| IPO Year | 2021 | 2017 |
| Metric | LENZ | ANGI |
|---|---|---|
| Price | $7.79 | $5.13 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 7 |
| Target Price | ★ $44.00 | $17.00 |
| AVG Volume (30 Days) | 734.8K | ★ 1.3M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1242.86 |
| EPS | N/A | ★ N/A |
| Revenue | $19,088,000.00 | ★ $736,386,000.00 |
| Revenue This Year | $50.42 | $3.25 |
| Revenue Next Year | $197.16 | $3.76 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 47.60 |
| 52 Week Low | $8.25 | $4.53 |
| 52 Week High | $50.19 | $19.42 |
| Indicator | LENZ | ANGI |
|---|---|---|
| Relative Strength Index (RSI) | 34.69 | 35.02 |
| Support Level | N/A | N/A |
| Resistance Level | $10.34 | $8.03 |
| Average True Range (ATR) | 0.64 | 0.59 |
| MACD | 0.02 | -0.22 |
| Stochastic Oscillator | 28.21 | 20.03 |
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
Angi Inc connects quality home service professionals with consumers across different categories, from repairing and remodeling to cleaning and landscaping. It operates through brands like Angi, HomeAdvisor, and Handy. The company has three operating segments, namely, Ads and Leads, Services, and International (Europe and Canada). A majority of its revenue is generated from the Ads and Leads segment, which provides professionals the capability to engage with potential customers, including quoting and invoicing services, and provides consumers with tools and resources to help them find professionals nationwide for home repair, maintenance, and improvement projects. Geographically, the company derives its key revenue from the United States and also has a presence in other countries.